Unknown

Dataset Information

JAK inhibition ameliorates bone destruction by simultaneously targeting mature osteoclasts and their precursors.


ABSTRACT:

Background

Rheumatoid arthritis (RA) is characterized by chronic inflammation and resultant cartilage/bone destruction because of aberrantly activated osteoclasts. Recently, novel treatments with several Janus kinase (JAK) inhibitors have been shown to successfully ameliorate arthritis-related inflammation and bone erosion, although their mechanisms of action for limiting bone destruction remain unclear. Here, we examined the effects of a JAK inhibitor on mature osteoclasts and their precursors by intravital multiphoton imaging.

Methods

Inflammatory bone destruction was induced by local injection of lipopolysaccharides into transgenic mice carrying reporters for mature osteoclasts or their precursors. Mice were treated with the JAK inhibitor, ABT-317, which selectively inhib

SUBMITTER: Yari S 

PROVIDER: S-EPMC9983229 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature